Related Experiment Video
Updated: Jun 10, 2026
07:05
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Update on botulinum toxin and dermal fillers.
Zachary J Berbos1, William J Lipham
1Department of Ophthalmology, University of Minnesota, Minneapolis, Minnesota, USA.
Current Opinion in Ophthalmology
|August 13, 2010
Summary
Botulinum toxin and dermal fillers are increasingly popular for facial rejuvenation. These minimally invasive treatments effectively reduce wrinkles, restore volume, and contour the face for a more youthful appearance.
Area of Science:
- Aesthetic Medicine
- Dermatology
- Cosmetic Surgery
Background:
- Facial rejuvenation is a dynamic medical field with continuous advancements in treatments.
- The utilization of botulinum toxin and dermal fillers for aesthetic enhancement has significantly increased over the last decade.
Purpose of the Study:
- To review the properties of commonly used injectable products for facial rejuvenation.
- To provide foundational guidance on the application of these injectables for aesthetic outcomes.
Main Methods:
- Review of properties of popular injectable products.
- Discussion of basic application techniques for facial rejuvenation.
Main Results:
- Nonsurgical injectable treatments for facial rejuvenation are in high demand.
- Botulinum toxin and dermal fillers offer cost-effective, minimally invasive options for facial rejuvenation.
- These agents can be used alone or in combination.
Conclusions:
- Botulinum toxin and dermal fillers effectively diminish facial wrinkles.
- These injectables restore facial volume and sculpt facial contours.
- Achieving an aesthetically pleasing and youthful facial appearance is possible with these treatments.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...